Patanjali misleading ads case: Kerala court summons Baba Ramdev and Acharya Balkrishna

A Kerala Court has directed Patanjali Ayurved Co-founder Baba Ramdev and its Managing Director Acharya Balkrishna to appear before it on June 03, 2024 in a case of publishing misleading advertisements in English and Malayalam newspapers.

By  Storyboard18May 23, 2024 8:32 AM
Patanjali misleading ads case: Kerala court summons Baba Ramdev and Acharya Balkrishna
Baba Ramdev’s Patanjali has been under scrutiny for issuing misleading advertisements for health cures. Last month, the Supreme Court lambasted both Ramdev and Acharya Balkrishna of Patanjali for advertisements that promoted the Ayush treatment system while undermining modern, evidence-based medicine and asked them to tender a public apology.

Yoga guru Baba Ramdev and his associate Acharya Balkrishna have been asked to appear before the Judicial First Class Magistrate Court in Kozhikode on June 3 in a case related to placing misleading advertisements in English and Malayalam newspapers. Both are founders of Haridwar-based Divya Pharmacy that markets Patanjali Ayurved’s products; Acharya Balkrishna is also its Managing Director.

This comes after the Drugs Inspector, Office of the Assistant Drugs Controller, Kozhikode filed a complaint in Kozhikode Court against Divya Pharmacy. The case has been filed under Section 3 of The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. Section 3 prohibits the advertisement of certain drugs for the treatment of certain diseases and disorders.

The specific allegation was misleading advertisements were published claiming that “Divya Lipdom” tablet manufactured by Divya Pharmacy claimed to reduce abnormal levels of cholesterol and fat in the body and to improve fat metabolism. And, the product “Nutrella Diabetic Care” manufactured by Patanjali Ayurved claims to manage blood sugar levels and body weight.

Baba Ramdev’s Patanjali has been under scrutiny for issuing misleading advertisements for health cures. Last month, the Supreme Court lambasted both Ramdev and Acharya Balkrishna of Patanjali for advertisements that promoted the Ayush treatment system while undermining modern, evidence-based medicine and asked them to tender a public apology.

After issuing the apology, the duo later asked the SC for time to file affidavit regarding steps taken to recall advertisement for medicines for which the company’s license was revoked. The SC granted them a period of three weeks.

First Published on May 23, 2024 8:32 AM

More from Storyboard18

Brand Marketing

Reliance Retail Ventures posts 11.3% rise in revenue to Rs 84,171 crore in Q1 FY26

Reliance Retail Ventures posts 11.3% rise in revenue to Rs 84,171 crore in Q1 FY26

Brand Marketing

Perplexity AI overtakes ChatGPT on App Store after Airtel deal sparks download surge

Perplexity AI overtakes ChatGPT on App Store after Airtel deal sparks download surge

Brand Marketing

No dyes, no flavors: PepsiCo goes all-in on 'real food' for snack rebrand

No dyes, no flavors: PepsiCo goes all-in on 'real food' for snack rebrand

Brand Makers

Larry Ellison, world's second richest man, launches global tech institute with Oxford

Larry Ellison, world's second richest man, launches global tech institute with Oxford

Brand Marketing

Airtel-Perplexity AI tie-up sparks online chatter over Apple, ads, and AI adoption

Airtel-Perplexity AI tie-up sparks online chatter over Apple, ads, and AI adoption

Brand Marketing

OpenAI launches general purpose "ChatGPT Agent" for automated task completion

OpenAI launches general purpose "ChatGPT Agent" for automated task completion

How it Works

YouTube Premium's muffled pitch: Why a "sound strategy" isn't converting in India

YouTube Premium's muffled pitch: Why a "sound strategy" isn't converting in India

Brand Makers

PepsiCo sees strong Q2 growth in India; Snacks, beverages drive international surge

PepsiCo sees strong Q2 growth in India; Snacks, beverages drive international surge